Salivary Intraductal Carcinoma Arising within Intraparotid Lymph Node: A Report of 4 Cases with Identification of a Novel STRN-ALK Fusion.
Intraductal carcinoma
Intranodal tumors
NCOA4-RET
STRN-ALK
Salivary gland neoplasms
Journal
Head and neck pathology
ISSN: 1936-0568
Titre abrégé: Head Neck Pathol
Pays: United States
ID NLM: 101304010
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
02
06
2020
accepted:
01
07
2020
pubmed:
15
7
2020
medline:
12
11
2021
entrez:
15
7
2020
Statut:
ppublish
Résumé
Intraductal carcinoma (IDC) is a rare salivary gland tumor that is considered analogous to ductal carcinoma in-situ of the breast, demonstrating a complex neoplastic epithelial proliferation surrounded by a continuous layer of presumed non-neoplastic myoepithelial cells. It is subcategorized into intercalated duct, apocrine, and hybrid subtypes based on morphologic and immunohistochemical features, with frequent NCOA4-RET and TRIM27-RET fusions, respectively, seen in intercalated duct and hybrid tumors. However, as an expanding clinicopathologic spectrum of IDC has been documented, controversy has emerged as to whether this tumor type is best defined by its intraductal growth pattern or distinctive molecular and immunophenotypic differentiation. Here, we further explore the nature of IDC by evaluating four cases that arose within intraparotid lymph nodes. These intercalated-duct phenotype tumors with diffuse S100 protein expression demonstrated a crowded and complex epithelial proliferation arranged in cystic, cribriform, and micropapillary architecture, surrounded by an intact myoepithelial cell layer, and were completely intranodal. Of two tumors with tissue available for molecular analysis, one demonstrated a NCOA4-RET fusion and one harbored a STRN-ALK fusion that is novel to IDC. Not only does the intranodal presence of IDC present a challenging differential diagnosis, but the complex nature of this proliferation within lymph node tissue raises questions as to whether the myoepithelial component of IDC is actually non-neoplastic in nature. Furthermore, identification of a STRN-ALK fusion expands the genetic spectrum of IDC and adds to evidence of an emerging role for ALK in salivary gland tumors. Further attention to the nature of the myoepithelial cells and documentation of alternate fusion events in IDC may inform continued discussion about its appropriate classification.
Identifiants
pubmed: 32661669
doi: 10.1007/s12105-020-01198-0
pii: 10.1007/s12105-020-01198-0
pmc: PMC8010048
doi:
Substances chimiques
Oncogene Proteins, Fusion
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
179-185Références
Virchows Arch. 2012 May;460(5):467-72
pubmed: 22476402
J Laryngol Otol. 1983 Feb;97(2):189-91
pubmed: 6298331
Head Neck Pathol. 2020 Sep;14(3):630-636
pubmed: 31605313
Int J Oral Maxillofac Surg. 1993 Oct;22(5):289-91
pubmed: 8245569
Head Neck Pathol. 2020 Sep;14(3):593-597
pubmed: 31541432
Clin Cancer Res. 2016 Sep 15;22(18):4623-33
pubmed: 27103403
Am J Surg Pathol. 2018 Apr;42(4):442-452
pubmed: 29443014
Eur J Endocrinol. 2018 Jan;178(1):83-91
pubmed: 29046324
Virchows Arch. 2020 Oct;477(4):581-592
pubmed: 32383006
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4233-8
pubmed: 24613930
Oncol Rep. 1997 May-Jun;4(3):515-6
pubmed: 21590088
Malays J Pathol. 2019 Aug;41(2):207-211
pubmed: 31427558
Am J Surg Pathol. 2016 Jun;40(6):761-9
pubmed: 26848800
Head Neck Pathol. 2020 Mar;14(1):239-245
pubmed: 30610524
Mayo Clin Proc Innov Qual Outcomes. 2017 Apr 27;1(1):111-116
pubmed: 30225407
Cancer. 1996 Sep 1;78(5):958-67
pubmed: 8780532
Cancer. 1980 Mar 1;45(5):967-72
pubmed: 7260848
Genome Biol. 2019 Oct 21;20(1):213
pubmed: 31639029
Head Neck. 2016 Apr;38 Suppl 1:E1838-47
pubmed: 26699379
Head Neck Pathol. 2011 Sep;5(3):321-5
pubmed: 21442195
Int J Oral Maxillofac Surg. 1992 Jun;21(3):166-71
pubmed: 1640129
Histopathology. 2008 Oct;53(4):416-25
pubmed: 18983607
Int J Oral Surg. 1973;2(1):26-30
pubmed: 4201920
Cancer. 1985 Jan 15;55(2):400-3
pubmed: 3965095
Endocr Relat Cancer. 2019 Nov;26(11):803-814
pubmed: 31539879
Mod Pathol. 2017 Dec;30(12):1760-1772
pubmed: 28776573
Pathol Res Pract. 2017 Jun;213(6):706-709
pubmed: 28551385
Am J Surg Pathol. 2018 Nov;42(11):1445-1455
pubmed: 30045065
PLoS One. 2014 Jan 27;9(1):e87170
pubmed: 24475247
Head Neck Pathol. 2020 Dec;14(4):869-875
pubmed: 31989433
Am J Surg Pathol. 2006 Aug;30(8):1014-21
pubmed: 16861974
Hum Pathol. 2019 Jun;88:66-77
pubmed: 30946933
J Thorac Oncol. 2017 Dec;12(12):e202-e204
pubmed: 29169525
Clin Cancer Res. 2016 Aug 1;22(15):3831-40
pubmed: 26933125
Am J Surg Pathol. 2004 Aug;28(8):1040-4
pubmed: 15252310
Am J Surg Pathol. 2019 Oct;43(10):1303-1313
pubmed: 31162284
Eur Arch Otorhinolaryngol. 2013 Sep;270(9):2397-402
pubmed: 23229644
Am J Surg Pathol. 2020 Jul;44(7):962-969
pubmed: 32205481
Hum Pathol. 2019 Jan;83:50-58
pubmed: 30130630